Wonbiogen Co., Ltd. (KOSDAQ:307280)
6,620.00
-340.00 (-4.89%)
At close: Apr 2, 2026
Wonbiogen Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,260 | 7,196 | 3,036 | 3,226 | 7,671 |
Short-Term Investments | 7,100 | 3,675 | 5,520 | 5,347 | 6,087 |
Cash & Short-Term Investments | 15,360 | 10,870 | 8,556 | 8,573 | 13,758 |
Cash Growth | 41.30% | 27.05% | -0.19% | -37.69% | 1000.25% |
Accounts Receivable | 5,347 | 4,823 | 4,939 | 3,181 | 3,545 |
Other Receivables | 161.82 | 81.32 | 79.55 | 164.73 | 293.1 |
Receivables | 5,508 | 4,905 | 5,241 | 3,346 | 3,838 |
Inventory | 5,898 | 5,524 | 7,064 | 5,849 | 4,912 |
Prepaid Expenses | 87.08 | 67.63 | 84.99 | 94.78 | 82.43 |
Other Current Assets | 217.19 | 290.39 | 191.52 | 341.28 | 298.52 |
Total Current Assets | 27,071 | 21,657 | 21,138 | 18,204 | 22,889 |
Property, Plant & Equipment | 17,863 | 16,982 | 17,711 | 17,268 | 11,688 |
Long-Term Investments | 1,104 | 905.49 | 1,978 | 1,454 | 1,550 |
Goodwill | 151.98 | 313.76 | 510.41 | 510.41 | 510.41 |
Other Intangible Assets | 395.44 | 406.6 | 444.29 | 424.72 | 418.21 |
Long-Term Deferred Tax Assets | 470.11 | 453.48 | 323.54 | 323.2 | 155.28 |
Other Long-Term Assets | 569.07 | 550.57 | 798.14 | 748.16 | 832.77 |
Total Assets | 47,625 | 41,269 | 42,903 | 38,933 | 38,043 |
Accounts Payable | 1,110 | 837.8 | 696.58 | 721.73 | 1,036 |
Accrued Expenses | 565.39 | 456.76 | 385.17 | 364.73 | 304.69 |
Short-Term Debt | - | 200 | 6,360 | 8,700 | 7,494 |
Current Portion of Long-Term Debt | 366.67 | 50 | - | 48.27 | 73.2 |
Current Portion of Leases | 250.15 | 163.09 | 268.28 | 198.62 | 195.88 |
Current Income Taxes Payable | 789.9 | 694.06 | 852.76 | 704.54 | 2.98 |
Current Unearned Revenue | 57.44 | 40.12 | 37.88 | 14.76 | 61.21 |
Other Current Liabilities | 1,372 | 865.35 | 746.66 | 829.89 | 1,731 |
Total Current Liabilities | 4,511 | 3,307 | 9,347 | 11,583 | 10,899 |
Long-Term Debt | - | 366.67 | 416.67 | 9.99 | 58.26 |
Long-Term Leases | 313.83 | 112.47 | 272.84 | 244.29 | 267.51 |
Pension & Post-Retirement Benefits | 140.61 | 179.54 | 196.26 | 125.84 | 140.03 |
Other Long-Term Liabilities | 36.26 | 35.94 | 45.63 | 144.34 | 117.49 |
Total Liabilities | 5,002 | 4,002 | 10,279 | 12,107 | 11,482 |
Common Stock | 3,696 | 3,696 | 3,696 | 3,645 | 3,645 |
Additional Paid-In Capital | 7,520 | 7,520 | 7,520 | 6,925 | 35,611 |
Retained Earnings | 32,938 | 30,031 | 25,047 | 19,909 | -12,106 |
Treasury Stock | -383.05 | -2,996 | -2,996 | -2,996 | - |
Comprehensive Income & Other | -1,045 | -1,045 | -1,045 | -615.82 | -447.54 |
Total Common Equity | 42,726 | 37,207 | 32,222 | 26,867 | 26,703 |
Minority Interest | -102.55 | 60.65 | 402.62 | -41.74 | -141.84 |
Shareholders' Equity | 42,624 | 37,268 | 32,625 | 26,826 | 26,561 |
Total Liabilities & Equity | 47,625 | 41,269 | 42,903 | 38,933 | 38,043 |
Total Debt | 930.65 | 892.23 | 7,318 | 9,201 | 8,089 |
Net Cash (Debt) | 14,430 | 9,978 | 1,238 | -628.38 | 5,669 |
Net Cash Growth | 44.61% | 705.69% | - | - | - |
Net Cash Per Share | 2035.11 | 1406.50 | 162.84 | -87.33 | 816.08 |
Filing Date Shares Outstanding | 7.08 | 7.09 | 7.09 | 6.99 | 7.29 |
Total Common Shares Outstanding | 7.08 | 7.09 | 7.09 | 6.99 | 7.29 |
Working Capital | 22,560 | 18,350 | 11,790 | 6,621 | 11,990 |
Book Value Per Share | 6035.34 | 5244.41 | 4541.80 | 3841.64 | 3662.55 |
Tangible Book Value | 42,179 | 36,487 | 31,267 | 25,932 | 25,775 |
Tangible Book Value Per Share | 5958.01 | 5142.88 | 4407.23 | 3707.93 | 3535.18 |
Land | 5,658 | 5,622 | 5,550 | 5,340 | 3,582 |
Buildings | 7,458 | 7,389 | 7,248 | 6,942 | 3,417 |
Machinery | 8,815 | 9,083 | 8,673 | 7,686 | 6,510 |
Construction In Progress | 1,155 | 30 | 96.2 | 322.75 | 1,083 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.